Vandervelpen Nico 4
4 · Minerva Neurosciences, Inc. · Filed Jul 26, 2017
Insider Transaction Report
Form 4
Vandervelpen Nico
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-07-24+12,500→ 12,500 totalExercise: $10.20Exp: 2018-07-24→ Common Stock (12,500 underlying) - Award
Stock Option (Right to Buy)
2017-07-24+25,000→ 25,000 totalExercise: $4.71Exp: 2018-07-24→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-07-24−12,500→ 0 totalExercise: $10.00Exp: 2027-05-31→ Common Stock (12,500 underlying) - Award
Stock Option (Right to Buy)
2017-07-24+12,500→ 12,500 totalExercise: $10.00Exp: 2018-07-24→ Common Stock (12,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-07-24−12,500→ 0 totalExercise: $10.20Exp: 2026-06-15→ Common Stock (12,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-07-24−25,000→ 0 totalExercise: $4.71Exp: 2025-12-03→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 4, 2015 and provides for vesting quarterly over 3 years beginning on December 4, 2015.
- [F2]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 16, 2016 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 16, 2016 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.
- [F3]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 1, 2017 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.